March 30, 2012 — (BRONX, NY) — Three leading cancer researchers at Albert Einstein College of Medicine of Yeshiva University have been selected to chair symposia at this year’s annual meeting of the American Association for Cancer Research, which will be held in Chicago from March 31 to April 4.
(L to R): John Condeelis, Ph.D., Jeffrey Pollard, Ph.D., Matthew Gamble, Ph.D.The major symposium, "Immune Cell Function and Cancer In Vivo: Visualizing Friends and Foes," will be led by John Condeelis, Ph.D., professor and co-chair of anatomy and structural biology, co-director of the Gruss Lipper Biophotonics Center, director of the program in tumor microenvironment in the Albert Einstein Cancer Center, and holder of the Judith and Burton P. Resnick Chair in Translational Research at Einstein. In this symposium, scheduled for Tuesday, April 3, researchers will highlight innovative imaging technologies – ranging from single-cell detection capabilities to rapid whole-body imaging – for studying how cancer cells evade, interact with, and mimic immune cells in order to grow and spread.
A second major symposium, "Modulating Antitumor Responses by Stromal Cells and Innate Immunity," will be chaired by Jeffrey Pollard, Ph.D., professor of developmental and molecular biology and of obstetrics & gynecology and women’s health. He also holds the Louis Goldstein Swan Chair in Women's Cancer Research and is the deputy director of the Albert Einstein Cancer Center. The symposium, held on Wednesday, April 4, will focus on the tumor microenvironment – a complex ecology of malignant and normal cells that evolves to support tumor cells during their progression to malignancy – and how to manipulate it to suppress cancer growth.
Ten other Einstein researchers will make presentations at the AACR annual meeting. The presenters are: